Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

AI can accurately measure hair loss severity in alopecia areata.

Cosmetic dermatology is improving with new technologies but faces ethical and regulatory challenges.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.

Androgenetic alopecia causes hair loss, and early, ongoing treatment is key for best results.

Cosmeceuticals effectively treat skin issues but need better regulation and safety measures.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Lymph vessels in airways vary by location, with the most in the upper pharynx and changes after birth.

Early intervention and continuous treatment are key for managing hereditary hair loss effectively.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Hair follicles and deer antlers regenerate similarly through stem cells and are influenced by hormones and growth factors.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

AI in dermatology is growing rapidly, showing promise in diagnosing skin conditions as accurately as dermatologists.

New imaging technologies improve skin diagnosis but face cost and training challenges.

Robotic surgery in plastic and reconstructive procedures improves precision and outcomes but faces challenges like high costs and long operating times.

The AI model accurately classifies Alopecia Areata with 96.94% accuracy.

Exosome therapies could help with skin and hair issues, but more testing is needed.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Robotic systems in cosmetic surgery are promising but need more development and research.

A child has a rare hair and skin disorder due to specific gene variants, suggesting broader genetic testing is needed.

HairLossMultinet accurately classifies hair damage with 98% accuracy but needs a more diverse dataset for broader use.

The metaverse offers potential for managing hair and nail disorders but faces challenges like technology limits and accessibility.

AI can effectively predict COVID-19 mortality risk using patient data.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

AI and AR are improving cosmetic dermatology but face challenges like data quality and ethical concerns.

A group has developed therapies that show promise for treating cancer and various other conditions.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Different fibroblasts play key roles in skin healing and scarring.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.